These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 8062825)

  • 1. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
    Lovec H; Grzeschiczek A; Kowalski MB; Möröy T
    EMBO J; 1994 Aug; 13(15):3487-95. PubMed ID: 8062825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.
    Bodrug SE; Warner BJ; Bath ML; Lindeman GJ; Harris AW; Adams JM
    EMBO J; 1994 May; 13(9):2124-30. PubMed ID: 8187765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 as the putative bcl-1 oncogene.
    Harris AW; Bodrug SE; Warner BJ; Bath ML; Lindeman GJ; Adams JM
    Curr Top Microbiol Immunol; 1995; 194():347-53. PubMed ID: 7895508
    [No Abstract]   [Full Text] [Related]  

  • 4. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
    Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
    Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transgenic window on lymphoid malignancy.
    Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
    Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
    Haas K; Staller P; Geisen C; Bartek J; Eilers M; Möröy T
    Oncogene; 1997 Jul; 15(2):179-92. PubMed ID: 9244353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
    Uchimaru K; Taniguchi T; Yoshikawa M; Asano S; Arnold A; Fujita T; Motokura T
    Blood; 1997 Feb; 89(3):965-74. PubMed ID: 9028328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia.
    Linden MA; Kirchhof N; Carlson CS; Van Ness BG
    Exp Hematol; 2012 Mar; 40(3):216-27. PubMed ID: 22120021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.
    Möröy T; Fisher P; Guidos C; Ma A; Zimmerman K; Tesfaye A; DePinho R; Weissman I; Alt FW
    EMBO J; 1990 Nov; 9(11):3659-66. PubMed ID: 2120050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice.
    Möröy T; Fisher PE; Lee G; Achacoso P; Wiener F; Alt FW
    J Exp Med; 1992 Feb; 175(2):313-22. PubMed ID: 1310099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
    Lukas J; Jadayel D; Bartkova J; Nacheva E; Dyer MJ; Strauss M; Bartek J
    Oncogene; 1994 Aug; 9(8):2159-67. PubMed ID: 8036001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
    Alexander WS; Schrader JW; Adams JM
    Mol Cell Biol; 1987 Apr; 7(4):1436-44. PubMed ID: 3037318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression.
    Dildrop R; Ma A; Zimmerman K; Hsu E; Tesfaye A; DePinho R; Alt FW
    EMBO J; 1989 Apr; 8(4):1121-8. PubMed ID: 2501083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D and oncogenesis.
    Motokura T; Arnold A
    Curr Opin Genet Dev; 1993 Feb; 3(1):5-10. PubMed ID: 8453274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
    Uchimaru K; Endo K; Fujinuma H; Zukerberg L; Arnold A; Motokura T
    Jpn J Cancer Res; 1996 May; 87(5):459-65. PubMed ID: 8641982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
    Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
    Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.